Edwards' SAPIEN 3 Ultra Transcatheter Heart Valve Receives CE Mark
IRVINE, Calif., Nov. 16, 2018 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it has rece... Devices, Interventional, Cardiology, Regulatory Edwards Lifesciences, SAPIEN 3 Ultra, Transcatheter, Heart Valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2018 Category: Pharmaceuticals Source Type: news

United Imaging Healthcare Announces Appointment of World-Renowned Expert as Senior Scientific Advisor
Prof. Dr. Hermann Requardt to provide strategic guidance on technology and R&D SHANGHAI, Nov. 16, 2018 -- (Healthcare Sales & Marketing Network) -- United Imaging Healthcare Co., Ltd. (UIH), an international leader in advanced medical imaging and radio... Devices, Radiology, Personnel United Imaging Healthcare Co, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2018 Category: Pharmaceuticals Source Type: news

New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Neurostimulation of the dorsal root ganglion (DRG) can provide pain relief for patients battling chronic pain when previous treatment options were unsuccessful Abbott's new DRG Invisible Trial System brings an intuitive, wireless approach to the tempora... Devices, Neurology, FDA, Regulatory, Product Launch Abbott, dorsal root ganglion, neurostimulation, DRG Invisible Trial (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2018 Category: Pharmaceuticals Source Type: news

NuVasive Launches First-Of-Its-Kind Brigade(R) Lateral Implant And Instrumentation Optimized For Lateral Anterior Lumbar Interbody Fusion Spine Surgery
SAN DIEGO, Nov. 15, 2018 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today annou... Devices, Orthopaedic, Neurosurgery, Product Launch NuVasive, Brigade Lateral, anterior lumbar, interbody fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2018 Category: Pharmaceuticals Source Type: news

Abyrx(R) Appoints Gary D. Cohn as Director
Former Director of the U.S. National Economic Council and Goldman Sachs COO joins biomaterial sciences company Board of Directors Abyrx products have been used over 200,000 times in 600+ hospitals in the U.S. NEW YORK, Nov. 14, 2018 -- (Healthcare Sa... Devices, Surgery, Personnel Abyrx (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2018 Category: Pharmaceuticals Source Type: news

Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs
SAN FRANCISCO, Nov. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Nektar Therapeutics (Nasdaq: NKTR) today announced the appointment of Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs. In this... Biopharmaceuticals, Oncology, Personnel Nektar Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2018 Category: Pharmaceuticals Source Type: news

Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
Precision BioSciences gains rights to MaxCyte's cell engineering technology to develop next-generation, oncology-focused, cell therapies with Precision's ARCUS® genome-editing technology DURHAM, N.C. and GAITHERSBURG, Md., Nov. 14, 2018 -- (Healthca... Biopharmaceuticals, Oncology, Licensing MaxCyte, Precision BioSciences, Flow Electroporation, ARCUS genome-editing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2018 Category: Pharmaceuticals Source Type: news

Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Lilly also plans to submit a supplemental Biologics License Application (sBLA) to the FDA for Emgality for the preventive treatment of episodic cluster headache by the end of the year, reflecting its commitment to disabling headache disorders INDIANAPOL... Biopharmaceuticals, Neurology, FDA Eli Lilly, lasmiditan, migraine, Emgality, galcanezumab-gnlm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2018 Category: Pharmaceuticals Source Type: news

Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
AACHEN, Germany and MORRISTOWN, New Jersey, November 14, 2018 -- (Healthcare Sales & Marketing Network) - Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ... Biopharmaceuticals, Mergers & Acquisitions Grünenthal Group, Averitas Pharma, Qutenza, capsaicin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2018 Category: Pharmaceuticals Source Type: news

STERIBITE(R) Announces FDA Clearance of the Steribite Disposable Kerrison Rongeur
CLEVELAND, Nov. 13, 2018 -- (Healthcare Sales & Marketing Network) -- STERIBITE, LLC, a medical device company focused on developing unique, disposable surgical instruments, today announced it has received 510(k) clearance from the FDA to market its first... Devices, Orthopaedic, Neurosurgery, FDA STERIBITE, Kerrison Rongeur, Rongeur (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

NeuroStar(R) Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment
TMS therapy provider will be offering NeuroStar Advanced Therapy at six new locations MALVERN, Pa., Nov. 13, 2018 -- (Healthcare Sales & Marketing Network) -- NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation ... Devices, Neurology, Distribution NeuroStar Advanced Therapy, GRW Health, transcranial magnetic stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

Kymera Therapeutics Announces $65 Million Series B Financing to Advance Pipeline of Targeted Protein Degraders in Oncology and Immunology
Series B financing led by 6 Dimensions Capital, Bessemer Venture Partners, and Pfizer Ventures Financing to enable the advancement of lead program into clinical development and support the progression of additional programs CAMBRIDGE, Mass., Nov. 13,... Biopharmaceuticals, Venture Capital, Personnel Kymera Therapeutics, Pegasus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

HOX Therapeutics Appoints Karl Keegan as Chief Executive Officer
Developing Targeted Therapies With Potential Applicability Across Many Cancer Types GUILDFORD, England, November 13, 2018 -- (Healthcare Sales & Marketing Network) -- HOX Therapeutics, the private biotechnology company developing first-in-class, highly... Biopharmaceuticals, Oncology, Personnel HOX Therapeutics, HOX genes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
STOCKHOLM, Nov. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has entered into agreements to acquire the perpetual rights to Synagis® (palivizumab) in the US from AstraZeneca and to partici... Biopharmaceuticals, Acquisitions Swedish Orphan Biovitrum, Sobi , AstraZeneca, Synagis, palivizumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

Cantel to Acquire Omnia S.p.A.
Acquisition of dental surgical consumables company will accelerate Company's dental infection prevention presence in Europe LITTLE FALLS, N.J., Nov. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Cantel Medical Corp. (NYSE: CMD), announced today... Devices, Dental, Surgery, Mergers & Acquisitions CANTEL MEDICAL, Omnia, medical device reprocessing, reprocessing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

Collidion Announces Settlement of Sonoma Litigation
PETALUMA, Calif., Nov. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Sonoma Pharmaceuticals, Inc. ("Sonoma") and Collidion Inc. ("Collidion") have today announced agreement to settle Sonoma's claims of trade secret misappropria... Biopharmaceuticals, Litigation Collidion, Sonoma Pharmaceuticals, hypochlorous acid (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine
Lannett Locks in $50 Million of Gross Profit for 16-Week Period PHILADELPHIA, Nov. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Amneal Pharmaceuticals... Biopharmaceuticals, Generics, Distribution Lannett Company, Amneal Pharmaceuticals, Levothyroxine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
Collaboration Combines CollPlant’s Proprietary rhCollagen-based BioInk Technology and United Therapeutics’ Regenerative Medicine and Organ Manufacturing Capabilities NESS ZIONA, Israel, November 12, 2018 -- (Healthcare Sales & Marketing Network) -- Col... Devices, Regenerative Medicine, Licensing CollPlant, United Therapeutics, Lung Biotechnology PBC, 3D bioprinting (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
This Announcement Contains Inside Information Within the Meaning of the EU Market Abuse Regulation No.596/2014 Arix's total interest in Harpoon increases to £20.2 million from £9.4 million Uplift of £4.7 million to Arix's most recen... Biopharmaceuticals, Oncology, Venture Capital Arix Bioscience, TriTAC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

FDA authorizes emergency use of first Ebola fingerstick test with portable reader
SILVER SPRING, Md., Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Today, the U.S. Food and Drug Administration announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Z... Diagnostics, FDA Chembio Diagnostic Systems, Ebola virus, DPP Ebola Antigen System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

ReWalk Announces Placement of 500th Exoskeleton System
Robotic exoskeleton manufacturer has provided life changing medical devices for persons with spinal cord injury in 26 countries MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- ReWalk Robotics Ltd. ... Devices ReWalk Robotics, robotic exoskeleton, exoskeleton, spinal cord injury (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

AbbVie Characterizes Evolving Hepatitis C (HCV) Patient Landscape in the United States Using Comprehensive Dataset
New MappingHepC.com website provides HCV community an easily accessible source of chronic HCV epidemiology data NORTH CHICAGO, Ill., Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutica... Biopharmaceuticals, Diagnostics AbbVie, Hepatitis C (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for solriamfetol, a selective dopamine... Biopharmaceuticals, Regulatory Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

OncoSec Appoints Robert Ward to its Board of Directors
Seasoned Biopharmaceutical Industry Leader Brings Extensive Experience in Drug Development and Commercialization SAN DIEGO and PENNINGTON, N.J., Nov. 8, 2018 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: O... Biopharmaceuticals, Oncology, Personnel OncoSec Medical, intratumoral cancer immunotherapies, TAVO (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2018 Category: Pharmaceuticals Source Type: news

Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
HOLLISTON, Mass., Nov. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today an... Devices, Regenerative Medicine, Personnel Biostage, bioengineered organ implant, Cellframe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2018 Category: Pharmaceuticals Source Type: news

Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors
Sharp to Bring Additional Financial Expertise to Sutro's Board SAN FRANCISCO, Nov. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Sutro Biopharma, Inc. (NASDAQ: STRO), today announced that Shalini Sharp, Chief Financial Officer and Executive Vice... Biopharmaceuticals, Oncology, Personnel Sutro Biopharma, XpressCF+ (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2018 Category: Pharmaceuticals Source Type: news

HemoScreen(TM) Hematology Analyzer for Point of Care, Receives FDA 510(k) Clearance
PixCell Medical's Point Of Care (POC) blood analyzer is the first cartridge-based system to be FDA cleared, providing all 20 CBC parameters. The HemoScreen™ should enable physicians to make more rapid and accurate decisions YOKNEAM, Israel, Nov. 7, 2... Devices, Diagnostics, FDA PixCell Medical, HemoScreen, blood analyzer, Lab On a Cartridge (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 7, 2018 Category: Pharmaceuticals Source Type: news

Ms. Ting Li Appointed to Biostage Board of Directors
HOLLISTON, Mass., Nov. 7, 2018 -- (Healthcare Sales & Marketing Network) -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus, and trachea, today a... Regenerative Medicine, Personnel Biostage, bioengineered organ implant, Cellframe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 7, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Ortho Clinical Diagnostics VITROS(R) Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator for use on the VITROS(R) 5600 Integrated System
Expanded use on the VITROS® 5600 Integrated System will help Labs Maximize Workflow Efficiencies RARITAN, N.J., Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced... Diagnostics, HIV/AIDS, FDA Ortho Clinical Diagnostics, VITROS, HIV Combo Reagent Pack (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news

Cumberland Pharmaceuticals To Acquire VIBATIV(R)
FDA approved injectable anti-infective with life-saving potential NASHVILLE, Tenn., Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it has entered into a definitive agreement... Biopharmaceuticals, Acquisitions Cumberland Pharmaceuticals, Theravance Biopharma, VIBATIV, telavancin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news

Biostage awarded $1.1 million Phase II NIH SBIR Fast-Track grant to develop Cellspan(TM) Esophageal Implant (CEI) as a novel treatment for pediatric esophageal atresia
These nondilutive funds support development, testing and IND submission of the Company's pediatric esophageal implant candidate HOLLISTON, Mass., Nov. 6­­­, 2018 -- (Healthcare Sales & Marketing Network) -- Biostage, Inc. (OTCQB: BSTG), a b... Regenerative Medicine Biostage, Cellspan, Esophageal Implant, Cellframe, esophageal atresia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news

Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products
Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019 PHILADELPHIA, Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has e... Biopharmaceuticals, Licensing, Distribution Lannett Company, Sunshine Lake, HEC Pharm Group, clarithromycin, entacapone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news

AandD Medical Partners with HRS to Deliver Advanced Biometric Monitoring to Telehealth Patients
HOBOKEN, N.J., Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- A&D Medical has partnered with Health Recovery Solutions (HRS) to bring the most cutting edge biometric monitoring equipment to patients using the HRS platform. A&D Medical has been ... Devices, Monitoring A&D Medical, Health Recovery Solutions, telehealth, biometric monitoring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news

Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
First and Only Hyaluronic Acid Dermal Filler for Cheeks with Cannula1 Now Offers Aesthetic Professionals New Delivery Method of Injectable Treatment FORT WORTH, Texas, Nov. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Galderma Laboratories, L.P... Devices, Dermatology, FDA Galderma Laboratories, Restylane, Restylane Lyft, dermal filler (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 5, 2018 Category: Pharmaceuticals Source Type: news

Biocept Announces New Executive Hires to its Sales and Marketing Organization
Appoints Scott Nicholson as Vice President of National Sales - US; Cory Dunn as Vice President of Marketing SAN DIEGO, Nov. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biops... Diagnostics, Oncology, Personnel Biocept, liquid biopsy, Target Selector, progesterone receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 5, 2018 Category: Pharmaceuticals Source Type: news

CMS Grants Outpatient Pass-through Payment to the remedand#275;(R) System for the Treatment of Central Sleep Apnea
Pass-through Payment to Provide Additional Medicare Reimbursement for the remedē System MINNETONKA, Minn., Nov. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Respicardia, Inc. announced today that the Centers for Medicare and Medicaid Servi... Devices, Neurology, Reimbursement Respicardia, remedē System, phrenic nerve stimulation, sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 5, 2018 Category: Pharmaceuticals Source Type: news

Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
Louis G. Lange, M.D., Ph.D. appointed as Lead Independent Director SAN FRANCISCO, Nov. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing in... Biopharmaceuticals, Personnel Audentes Therapeutics, Myotubular Myopathy, Crigler-Najjar syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 5, 2018 Category: Pharmaceuticals Source Type: news

Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology
HOLLAND, Mich., Nov. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System. This is a key addition to their expanding shoulder portfolio a... Devices, Orthopaedic, FDA Shoulder Innovations, InSet Humeral Short Stem, shoulder arthroplasty (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 5, 2018 Category: Pharmaceuticals Source Type: news

EMA Validates and Grants Accelerated Assessment of Marketing Authorization Application for Daiichi Sankyo's FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Application based on results of pivotal phase 3 QuANTUM-R study of quizartinib in patients with relapsed/refractory FLT3-ITD AML Quizartinib is the first FLT3 inhibitor to demonstrate a survival benefit in a randomized phase 3 study in patients with rel... Biopharmaceuticals, Oncology, Regulatory Daiichi Sankyo, quizartinib, acute myeloid leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 5, 2018 Category: Pharmaceuticals Source Type: news

TempTraq(R) Wearable Temperature Monitoring Patch Earns CE Mark Approval
TempTraq® Wearable, Bluetooth Temperature Monitor Provides Peace of Mind for Parents and Home Care Givers, and Sets a New Standard of Care for Hospitals in Europe CLEVELAND, Nov. 2, 2018 -- (Healthcare Sales & Marketing Network) -- Blue Spark Techn... Devices, Monitoring, Regulatory Blue Spark Technologies, TempTraq, temperature monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 2, 2018 Category: Pharmaceuticals Source Type: news

Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
SYMPAZAN is the first and only FDA-approved oral film formulation of clobazam, a benzodiazepine approved for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older(1) SYMPAZAN is delivered via ... Biopharmaceuticals, Drug Delivery, FDA Aquestive Therapeutics, SYMPAZAN, clobazam, PharmFilm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 2, 2018 Category: Pharmaceuticals Source Type: news

Torque Announces Appointment of Immunotherapy Pioneer F. Stephen Hodi, MD, to Scientific Advisory Board and Alex Bruni as COO/ CFO
CAMBRIDGE, Mass., Nov. 2, 2018 -- (Healthcare Sales & Marketing Network) -- Torque, an immuno-oncology company developing first-in-class Deep Primed™ T Cell Therapeutics to direct immune power deep within the tumor microenvironment, announced today the ap... Biopharmaceuticals, Oncology, Personnel Torque, Deep Primed T Cell, tumor microenvironment, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 2, 2018 Category: Pharmaceuticals Source Type: news

BioArctic's Partner AbbVie Exercises its Option to License the Alpha-synuclein Antibody Portfolio for Parkinson's Disease
STOCKHOLM, Oct. 2, 2018 -- (Healthcare Sales & Marketing Network) -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has received a Notice of Option Exercise under the Research, Development, Option and License Agreement dat... Biopharmaceuticals, Neurology, Licensing BioArctic, AbbVie, alpha-synuclein, Parkinson's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 2, 2018 Category: Pharmaceuticals Source Type: news

FDA's Center for Devices and Radiological Health and Center for Drug Evaluation and Research on agency's warning to consumers about genetic tests that claim to predict patients' responses to specific medications
SILVER SPRING, Md., Nov. 1, 2018 -- (Healthcare Sales & Marketing Network) -- As a public health agency, one of our key roles is to promote and advance safe and effective medical product innovations. One rapidly advancing, and very promising, area of scie... Biopharmaceuticals, Diagnostics, FDA FDA, genetic testing, pharmacogenetic testing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2018 Category: Pharmaceuticals Source Type: news

Cantel Appoints Bill Haydon to Senior Vice President and General Manager of Medical Division
LITTLE FALLS, N.J., Nov. 1, 2018 -- (Healthcare Sales & Marketing Network) -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Bill Haydon has been recently appointed to Senior Vice President and General Manager of the Medical division. Mr. Haydon wi... Devices, Personnel CANTEL MEDICAL, medical device reprocessing, reprocessing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2018 Category: Pharmaceuticals Source Type: news

OsteoRemedies(R) Announces the First FDA Cleared Dual-Antibiotic Spacer and Bone Cement with Gentamicin and Vancomycin
MEMPHIS, Tenn., Nov. 1, 2018 -- (Healthcare Sales & Marketing Network) -- OsteoRemedies®, LLC, a company focused on providing simple solutions to complex disorders, is pleased to announce the launch of the REMEDY SPECTRUM™️ GV Hip Spacer System... Devices, Orthopaedic, FDA OsteoRemedies, REMEDY SPECTRUM GV, Hip Spacer System, SPECTRUM GV, Bone Cement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2018 Category: Pharmaceuticals Source Type: news

Chris Cargill Appointed Executive Vice President and Chief Financial Officer of Sosei
TOKYO and LONDON, November 1, 2018 -- (Healthcare Sales & Marketing Network) -- Sosei Group Corporation ("Sosei" or "the Company"; TSE Mothers Index: 4565), a world-leading GPCR medicine design and development company, has appointed Mr... Biopharmaceuticals, Personnel Sosei Group (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2018 Category: Pharmaceuticals Source Type: news

Senhwa Biosciences Silmitasertib filed IND of Basal Cell Carcinoma approved by FDA
TAIPEI, Taiwan and SAN DIEGO, Nov. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Senhwa Biosciences Inc. (TPEx: 6492) announced today that FDA has approved its IND application for basal cell carcinoma (BCC). To accelerate the development of this ne... Biopharmaceuticals, Oncology, FDA Senhwa Biosciences, Silmitasertib, basal cell carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2018 Category: Pharmaceuticals Source Type: news

AbbVie Receives European Commission Approval of VENCLYXTO(R) (venetoclax) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy
The approval is based on the MURANO Phase 3 clinical trial, in which VENCLYXTO® plus rituximab reduced the risk of disease progression or death by 83 percent and overall survival was prolonged compared to bendamustine in combination with rituximab, a s... Biopharmaceuticals, Oncology, Regulatory AbbVie, VENCLYXTO, venetoclax, chronic lymphocytic leukemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2018 Category: Pharmaceuticals Source Type: news

1DROP Raises $4.25 Million to Develop Next-Generation Portable Medical Diagnostics
Investment will support commercialization and development of panels of new diagnostic tests BOSTON and NEUCHATEL, Switzerland, Oct. 31, 2018 -- (Healthcare Sales & Marketing Network) -- 1DROP, a life science company developing and commercializing an ea... Diagnostics, Venture Capital 1DROP (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 31, 2018 Category: Pharmaceuticals Source Type: news